CymaBay to Report Third Quarter 2017 Financial Results on Wednesday, November 8
NEWARK, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will …